Nasal spray of an IgM‐like ACE2 fusion protein HH‐120 prevents SARS‐CoV‐2 infection: Two investigator‐initiated postexposure prophylaxis trials
Song et al., Journal of Medical Virology, doi:10.1002/jmv.29275
https://c19early.org/song5.html